Top

Published in:

01-09-2020 | Anticoagulant | IM - COMMENTARY

The safety of anticoagulant therapy in the treatment of splanchnic vein thrombosis associated with acute pancreatitis

Authors: Omri Cohen, Walter Ageno

Published in: Internal and Emergency Medicine | Issue 6/2020

Excerpt

Acute pancreatitis (AP) is associated with significant morbidity, and has an annual incidence ranging from 13 to 45 per 100,000 persons [1]. It represents an important indication for hospital admission worldwide [2−4], and has a mortality rate of 1–7% which increases up to 10–28% in patients with severe AP [3−5]. The inflammation of the pancreas may be associated with a systemic inflammatory response syndrome that can lead to organ dysfunction and progress to organ failure [2]. The presence of inflammation, fluid collection, necrosis and infection can instigate both thrombotic and hemorrhagic complications [6−7]. …

Yadav D, Lowenfels AB (2013) The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144(6):1252–1261. https://doi.org/10.1053/j.gastro.2013.01.068CrossRefPubMedPubMedCentral

Krishna SG, Kamboj AK, Hart PA, Hinton A, Conwell DL (2017) The changing epidemiology of acute pancreatitis hospitalizations: a decade of trends and the impact of chronic pancreatitis. Pancreas 46(4):482–488. https://doi.org/10.1097/MPA.0000000000000783CrossRefPubMedPubMedCentral

Johnson CD, Besselink MG, Carter R (2014) Acute pancreatitis. BMJ 12(349):g4859. https://doi.org/10.1136/bmj.g4859CrossRef

Matta B, Gougol A, Gao X, Reddy N, Talukdar R et al (2019) Worldwide variations in demographics, management, and outcomes of acute pancreatitis. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2019.11.017(Epub ahead of print)CrossRefPubMed

Hines OJ, Pandol SJ (2019) Management of severe acute pancreatitis. BMJ 2(367):l6227. https://doi.org/10.1136/bmj.l6227CrossRef

Evans RP, Mourad MM, Pall G, Fisher SG, Bramhall SR (2017) Pancreatitis: preventing catastrophic haemorrhage. World J Gastroenterol 23(30):5460–5468. https://doi.org/10.3748/wjg.v23.i30.5460CrossRefPubMedPubMedCentral

Mallick IH, Winslet MC (2004) Vascular complications of pancreatitis. JOP J Pancreas 5(5):328–337

Valla DC, Condat B (2000) Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 32(5):865–871CrossRef

Ageno W, Dentali F, Squizzato A (2014) How I treat splanchnic vein thrombosis. Blood 124(25):3685–3691. https://doi.org/10.1182/blood-2014-07-551515(Epub 2014 Oct 15)CrossRefPubMed

10.

Nadkarni NA, Khanna S, Vege SS (2013) Splanchnic venous thrombosis and pancreatitis. Pancreas 42(6):924–931. https://doi.org/10.1097/MPA.0b013e318287cd3dCrossRefPubMed

11.

Derman BA, Kwaan HC (2015) Risk factors, diagnosis, management, and outcome of splanchnic vein thrombosis: a retrospective analysis. Semin Thromb Hemost 41(5):503–513. https://doi.org/10.1055/s-0035-1550429(Epub 2015 Jun 16)CrossRefPubMed

12.

Besselink MGH (2011) Splanchnic vein thrombosis complicating severe acute pancreatitis. HPB Off J Int Hepato Pancreato Biliary Assoc (Oxford) 13(12):831–832. https://doi.org/10.1111/j.1477-2574.2011.00411.xCrossRef

13.

Harris S, Nadkarni NA, Naina HV, Vege SS (2013) Splanchnic vein thrombosis in acute pancreatitis: a single-center experience. Pancreas 42(8):1251–1254. https://doi.org/10.1097/MPA.0b013e3182968ff5CrossRefPubMed

14.

Zhou J, Ke L, Yang D, Chen Y, Li G et al (2016) Predicting the clinical manifestations in necrotizing acute pancreatitis patients with splanchnic vein thrombosis. Pancreatology 16(6):973–978. https://doi.org/10.1016/j.pan.2016.10.001(Epub 2016 Oct 3)CrossRefPubMed

15.

Gonzelez HJ, Sahay SJ, Samadi B, Davidson BR, Rahman SH (2011) Splanchnic vein thrombosis in severe acute pancreatitis: a 2-year, single-institution experience. HPB (Oxford) 13(12):860–864. https://doi.org/10.1111/j.1477-2574.2011.00392.x(Epub 2011 Oct 12)CrossRef

16.

Butler JR, Eckert GJ, Zyromski NJ, Leonardi MJ, Lillemoe KD, Howard TJ (2011) Natural history of pancreatitis-induced splenic vein thrombosis: a systematic review and meta-analysis of its incidence and rate of gastrointestinal bleeding. HPB (Oxford) 13(12):839–845. https://doi.org/10.1111/j.1477-2574.2011.00375.x(Epub 2011 Oct 12)CrossRef

17.

Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e419S–e496S. https://doi.org/10.1378/chest.11-2301CrossRefPubMedPubMedCentral

18.

Valla D (2015) Splanchnic vein thrombosis. Semin Thromb Hemost 41(05):494–502. https://doi.org/10.1055/s-0035-1550439CrossRefPubMed

19.

Crockett SD, Wani S, Gardner TB, Falck-Ytter Y, Barkun AN et al (2018) American Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology 154(4):1096–1101. https://doi.org/10.1053/j.gastro.2018.01.032(Epub 2018 Feb 3)CrossRefPubMed

20.

Samarasekera E, Mahammed S, Carlisle S, Charnley R, Guideline Committee (2018) Pancreatitis: summary of NICE guidance. BMJ 362:k3443. https://doi.org/10.1136/bmj.k3443CrossRefPubMed

21.

Leppäniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E et al (2019) 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg 14:27. https://doi.org/10.1186/s13017-019-0247-0(Published online 2019 Jun 13)CrossRefPubMedPubMedCentral

22.

Senzolo M, Riva N, Dentali F, Rodriguez-Castro K, Sartori MT et al (2018) Long-term outcome of splanchnic vein thrombosis in cirrhosis. Clin Transl Gastroenterol 9(8):176. https://doi.org/10.1038/s41424-018-0043-2CrossRefPubMedPubMedCentral

23.

Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC et al (2001) Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 120(2):490–497CrossRef

24.

Amitrano L, Guardascione MA, Scaglione M, Pezzullo L, Sangiuliano N et al (2007) Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 102(11):2464–2470CrossRef

25.

Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F et al (2010) Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 51(1):210–218. https://doi.org/10.1002/hep.23259CrossRefPubMed

26.

Spaander MC, Hoekstra J, Hansen BE, Van Buuren HR, Leebeek FW, Janssen HL (2013) Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J Thromb Haemost 11(3):452–459. https://doi.org/10.1111/jth.12121CrossRefPubMed

27.

Janczak DT, Mimier MK, McBane RD, Kamath PS, Simmons BS et al (2018) Rivaroxaban and apixaban for initial treatment of acute venous thromboembolism of atypical location. Mayo Clin Proc 93(1):40–47. https://doi.org/10.1016/j.mayocp.2017.10.007CrossRefPubMed

28.

Salim S, Ekberg O, Elf J, Zarrouk M, Gottsäter A, Acosta S (2019) Evaluation of direct oral anticoagulants and vitamin K antagonists in mesenteric venous thrombosis. Phlebology 34(3):171–178. https://doi.org/10.1177/0268355518779517CrossRefPubMed

29.

Nagaoki Y, Aikata H, Daijyo K, Teraoka Y, Shinohara F et al (2018) Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis. Hepatol Res 48(1):51–58. https://doi.org/10.1111/hepr.12895CrossRefPubMed

30.

Intagliata NM, Henry ZH, Maitland H, Shah NL, Argo CK et al (2016) Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation. Dig Dis Sci 61(6):1721–1727. https://doi.org/10.1007/s10620-015-4012-2CrossRefPubMed

31.

Pagliari D, Cianci R, Brizi MG, Mancarella FA, Musso M et al (2020) Anticoagulant therapy in the treatment of splanchnic vein thrombosis associated to acute pancreatitis: a 3-year single-centre experience. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02271-5CrossRefPubMed

32.

Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD et al (2013) Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut 62(1):102–111. https://doi.org/10.1136/gutjnl-2012-302779CrossRefPubMed

Title: The safety of anticoagulant therapy in the treatment of splanchnic vein thrombosis associated with acute pancreatitis
Authors: Omri Cohen
Walter Ageno
Publication date: 01-09-2020
Publisher: Springer International Publishing
Keywords: Anticoagulant
Direct Oral Anticoagulant
Acute Pancreatitis
Thrombosis
Direct Oral Anticoagulant
Low Molecular Weight Heparin
Published in: Internal and Emergency Medicine / Issue 6/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-020-02336-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2020

Obstructive sleep apnea and blood pressure in young hypertensives: does it matter?

Evaluation of systo-diastolic cardiac function and arterial stiffness in subjects with new diagnosis of coeliac disease without cardiovascular risk factors

A 5-month history of fever and dry cough in a 67-year-old man

Human relationships in patients’ end-of-life: a qualitative study in a hospice ward

Acute intestinal ischaemia due to a foramen of Winslow hernia

Reading and interpreting reviews for health professionals: a practical review

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage